Oxford-AstraZeneca Vaccine Cleared by Expert Panel

India is just one step away from its first coronavirus vaccine. Soon, the approval will pave the way for the vaccine's rollout in India.

Drug Controller General of India (DCGI) has approved the emergency use of Oxford-AstraZeneca's Covishield vaccine and India is one step away from its first coronavirus vaccine.

The approval will pave the way for the vaccine's rollout in India, which also has the highest number of infections in the world, after the US. The rollout will begin from January 6, according to ministry sources.

Pfizer COVID-19 Vaccine for Emergency Use Approved
The World Health Organization (WHO) has granted emergency use validation for the Pfizer-BioNTech Covid-19 vaccine.

‘India is just one step away from its first coronavirus vaccine. Soon, the approval will pave the way for the vaccine's rollout in India.’

The UK and Argentina have already approved Covishield. More than five crore doses of the vaccine have already been stockpiled by its manufacturer, the Pune-based Serum Institute of India.

The expert panel had convened a meeting on afternoon to take a call on the emergency use authorisation sought by the Serum Institute and Bharat Biotech for their coronavirus vaccine candidates. Recommendations on latter's application is still awaited.

The Serum Institute had partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield' while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) to make 'Covaxin'.

Nurse in US Tests COVID-19 Positive 8 Days After Receiving Pfizer Shot
In California, a nurse has tested positive for coronavirus eight days after receiving the first dose of the Pfizer COVID-19 vaccine.

America's Pfizer was the first one to apply for the accelerated approval on December 4, followed by Serum and Bharat Biotech on December 6 and 7, respectively. Pfizer has, however, sought more time to present the data.

As India await a silver bullet against coronavirus with bated breath, the DCGI, on Thursday, hinted at the approval of vaccine and said that the country will have a "Happy New Year with something in hand".

MHRA Issues An Allergy Warning on Pfizer Vaccine After Allergies Were Reported
Any person with a history of anaphylaxis to a medicine or food should not be vaccinated with Pfizer-BioNTech COVID-19 vaccine states MHRA. Pfizer states allergic reactions had not been a feature of Pfizer’s clinical trials and was excluded.

The meeting of the expert panel came a day before dry run of the vaccine is slated to commence in all the states and Union Territories to equip the administration in management of vaccine supply, storage and logistics, including cold chain management.

The Central government plans to vaccinate nearly 30 crore people in the first phase of drive. It will be offered to one crore healthcare workers, along with 2 crore frontline and essential workers and 27 crore elderly, mostly above the age of 50 years with co-morbidities.

Pfizer-BioNTech Covid Vax Approved for Use by Singapore
Singapore on Monday followed a growing list of countries, including the US and the UK, in granting the use of the Pfizer-BioNTech vaccine to prevent Covid-19 in individuals aged 16 years and above.

Source-IANS